Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis

NCT01719159 is registered in ClinicalTrials.gov with Anders Svenningsson as lead sponsor.

NCT NCT01719159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01719159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple Sclerosis
Lead sponsor
Anders Svenningsson
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
June 30, 2016
Enrollment
23 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

progressive multiple sclerosis